The CRC DRAW study will assess the sensitivity and specificity of the blood-based, Next-Gen CRC Screening Test for the detection of CRC.
The CRC DRAW study is a prospective, multi-center, observational study to validate the Next-Gen CRC Screening test for the detection of CRC. The study will collect blood samples from average-risk participants scheduled for screening colonoscopies.
Study Type
OBSERVATIONAL
Enrollment
196
The Next-Gen CRC Screening Test is a blood-based screening test for detection of CRC.
Gastro SB
Chula Vista, California, United States
SDG Clinical Research
San Diego, California, United States
Medical Associates Research Group
San Diego, California, United States
Sensitivity for CRC of the Next-Gen CRC Screening Test
Clinical Performance
Time frame: blood collection up to 90 days from colonoscopy
Specificity for CRC of the Next-Gen CRC Screening Test
Clinical Performance
Time frame: blood collection up to 90 days from colonoscopy
Sensitivity for advanced precancerous lesions of the Next-Gen CRC Screening Test
Clinical Performance
Time frame: blood collection up to 90 days from colonoscopy
Specificity for no colorectal neoplastic findings of the Next-Gen CRC Screening Test
Clinical Performance
Time frame: blood collection up to 90 days from colonoscopy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.